BridgeMD
Tests treatment safety and results for Chronic Subdural Hematoma
Official title Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization
ClinicalTrials.gov ID: NCT05374681
What this study is testing
- What it's testing
- Chronic subdural hematomas (CSH) are collections of blood in the subdural space. CSH are becoming the most common cranial neurosurgical condition among adults, and a significant public health problem, due to an increasing use of anticoagulant and antiplatelet medication in an ageing population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with a more than 10 mm CSH confirmed by NCCT
- CSH localized to convexity
- Patient aged 18 years or more at the time of the enrollment
- Patient beneficiary from health insurance
You likely can't join if
- Any contraindication as required per angiogram procedure (severe renal failure ≥ 4, allergy…)
- Pre-existing severe disability resulting in baseline mRS score \> 3
- Life expectancy of less than 6 months due to another cause than CSH
- Patient under legal protection or deprived of liberty by a judicial or administrative decision
- Pregnant or breastfeeding women
- Vulnerable persons unable to give consent
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France, France
- Brest, France, France
- Caen, France, France
- Créteil, France, France
- Nantes, France, France
- Nice, France, France
- Paris, France, France
- Tours, France, France
- Bordeaux, France
- Nancy, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France, France; Brest, France, France; Caen, France, France; Créteil, France, France; Nantes, France, France; Nice, France, France and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.